Wintac Ltd's earnings have grown by 0%, whereas share price has appreciated 19.5% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.
Wintac Ltd share price has appreciated 27.5% annually (CAGR) over the past ten years.
Data is not available for this company.
Wintac Limited was started in the year 1987 with the name of Recon Limited and as an offspring of Bangalore Pharmaceutical and Research Laboratories Pvt. Ltd which has been in existence since 1956. The company shot into prominence for launching quality products which were within the reach of common man. Over the years, Recon leveraged its expertise in launching products that encompassed a wide range of therapeutic specialties.
In 2001 - Recon was renamed as Wintac
In 2001 - Recon was renamed as Wintac Limited, coined from We INtend TAking Care (WINTAC) its range of specialties includes Antifungal, Anticancer, Cardiovascular, Corticosterid , Antiemetic, Large and small volume injectable and Ophthalmic solutions.
Wintac Limited has now forayed into the field of critical care by manufacturing and marketing products targeted to the critically ill patients. It is a fully integrated pharmaceutical company that creates, develops, manufactures and distributes healthcare products that improve the quality of life. It currently, market specialty products under a strategic alliance between Tech I Ventures Inc., USA, Alza Corporation USA and other prospective business partners. It is thus committed to meet critical health needs by providing that winning edge in critical times. its success stems from its un-wavering commitment to technology.
The state-of-the-art manufacturing plant located at the outskirts of the city of Bangalore and has been awarded the ISO 9001 certification from DNV Germany. All the products manufactured here conform to stringent quality control, recommended and specified in the U. S, British and Indian pharmacopoeia. The facility which is on 16 acres of land has a total built-up area of over 85,000 sq. ft. and consists of a capsule unit and a sterile unit. The sterile unit is about 70,000 sq. ft. including exclusive suite for Ophthalmic preparation
Product range of the company includes:
Wintac is approved by AFSSAPS (Agence Francaise de Securite Sanitaire des Produits de Sante).
ISO 9001 certification from DNV Germany.